Cutting-edge biotechnology for scalable and sustainable protein production

We solve key challenges of scalable alternative protein production and provide our solutions as physical goods or licensable know-how to multiple industries.

Problem

Humanity is facing global challenges as key resources are diminishing.

Challenge

Difficulties in industrial scalability, reaching price parity for high quality and high yields of proteins.

Solution

The Cultivated B unlocks the full potential of biotechnology by taking it from the laboratory environment to industrial commodities.

While on the surface industries and their needs may look different …

Food

Demand for alternative proteins, improved animal welfare, sustainability and efficiency at scale.

Pharma

Explore naturally sourced ingredients, overcome limiting factors, high yield and cost-effectiveness.

Cosmetic & Personal Care

Animal free & vegan products, high-value materials for the conscious consumer, effectiveness and efficiency.

… our biotechnological approaches serve all these sectors efficiently.

We adjust based on the specific demand of your industry.

Our products

TCB
CELLS

TCB
RAW

TCB
MACHINES

TCB
SOLUTIONS

We provide highly innovative and science-driven biotechnology and bioengineering for the cellular agriculture, pharmaceutical, cosmetic and personal care industries. For sales inquiries, please contact our sales team.

Contact our team

News and press releases

n!Biomachines Partners with Weizmann Institute of Science to Validate and Advance Bioreactor Technology

BURLINGTON, CANADA, November 3, 2025 – n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, and the Weizmann Institute of Science have entered a Memorandum of Understanding (MOU) to validate and advance the functionality of n!Biomachines’ next-generation bioreactor systems.

Lambton College and n!Biomachines Ltd. Sign Memorandum of Understanding to Advance Cellular Agriculture Innovation in Canada

SARNIA, May 21, 2025 – Lambton College and n!Biomachines Ltd., a subsidiary of The Cultivated B., are pleased to announce the official signing of a Memorandum of Understanding (MOU) that marks the beginning of a collaborative effort to advance the field of cellular agriculture in Canada.

Our subsidiary n!Biomachines joins NVIDIA Connect Program

We’re proud to share that our subsidiary n!Biomachines has joined the NVIDIA Connect Program! As part of the Connect Program, we’re taking a significant step forward in our mission to enable smarter biomanufacturing.

Low-Cost Small Molecules to Replace bFGF, Enabling Stable and Scalable Cell Growth Benefitting R&D and Industrial Application

The Cultivated B reveals breakthrough discovering a chemical class of FGFR1 agonists mimicking bFGF’s effect on cell proliferation, an essential component of cell-culture media. This class of small molecules offers a stable, highly cost-effective alternative, poised to transform…

The Cultivated B Launches AI-Driven Multi-Channel Biosensors Enhancing Bioreactor Monitoring with Real Time Data Analytics

Burlington, Canada, February 5, 2025 – The Cultivated B today announced the launch of multi-channel biosensors that will set new benchmarks in monitoring growth and metabolism of cell culture and fermentation processes. By combining simultaneous tracking with AI-enabled real time analytics …